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1. Introduction 
Phosphoprotein phosphatase (PPase) activity in 
brain tissue has been reported [l-4]. Properties of a 
PPase solubilized from human central nervous ystem 
myelin described were [5 1. We now report on the 
presence of a high molecular weight form of the 
PPase (M, 250 000) found in extracts prepared from 
delipidated myelin. This high M, form of the enzyme 
has been converted to a small molecular weight species 
of M, 46 000. The latter has been purified to appar- 
ent homogeneity. We report on the substrate speciflc- 
ity and activation by divalent cations of the high 
molecular weight PPase. 
2. Materials and methods 
2.1. Materials 
Myelin basic protein was prepared from human 
brain by the method in [6]. Myelin was isolated from 
human brain as in [7]. Mixed histones, lysine-rich 
histones, arginine-rich histones, protamine, and cyclic 
AMP-dependent protein kinase were purchased from 
Sigma. [y-“P]ATP was purchased from New England 
Nuclear. 
2.2. Preparation of (32P_lphosphorylated substrates 
and assay of the phosphatase activity 
Phosphorylation of basic protein, histones, and 
protamine was mainly as in [8]. The [32P]phospho- 
proteins used here contained lo-40 nmol alkali- 
labile phosphatelmg protein. The phosphatase was 
* To whom correspondence should be addressed 
ElsevierfNorth-Holkmd Biomedical Press 
assayed by the modified method in [2]. The reaction 
mixture (100 /,.d) contained 50 mM Tris-HCl buffer 
(pH 7.5), 5 mM dithiothreitol, 4-6 /LM [32P] orthophos- 
phate moiety in the respective phosphoproteins, 125 
fl Mn2+, and appropriate amounts of the phosphatase. 
After a 20 min incubation at 37”C, the reaction was 
stopped by adding 20 /.d glacial acetic acid. Released 
orthophosphate was separated and quantitated as in 
[9]. Conditions for assays were selected so that the 
release of phosphate was proportional to the time of 
incubation and to the amount of enzyme protein 
added. One unit of phosphatase activity releases 
1 mnol [32P]phosphate/min from phosphoproteins. 
2.3. Isolation and purification of phosphoprotein 
phosphatase from human myelin 
Human myelin was stirred in 30 vol. ether/metha- 
nol (3:2, v/v) for 30 min at 4°C. After repeating the 
delipidation process twice, the suspension was centri- 
fuged at 12 000 X g for 10 min, and the pellet was 
dried under nitrogen. The myelin powder was homog- 
enized in 10 vol. 50 mM Tris-HCl buffer (PH 7.5) 
and centrifuged at 100 000 X g for 45 mm. The 
supernatant solution contained the high-molecular 
form of the PPase. The PPase was precipitated from 
the supernatant solution on the addition of ethanol 
to 80%. This step was done at room temperature as in 
[lo]. The resulting protein precipitate was collected 
by centrifugation, dissolved in a volume equal to that 
of the original extract in buffer A (50 mM Tris-HCl 
(pH 7.5), 20% glycerol, and 2 mM dithiothreitdl) 
then 1 .O ml enzyme solution was chromatographed 
on a Bio-gel A-l.5 m column (1 X 30 cm) using 
buffer A at 4°C. Fractions with phosphatase activity 
were pooled and chromatographed on a DE-52 cellu- 
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lose column (0.7 X 10 cm) equ~ibrated with buffer 
A. The column was developed with a linear gradient 
of 0.1-0.4 M NaCl in buffer A. Phosphatase activity 
was found to elute from 0.2-0.3 M NaCl. The active 
fractions were pooled and concentrated to 0.5 ml by 
ultrafiltration using Amicon PM-10 membrane. Finally 
the enzyme solution was chromatographed on a 
Sephadex G-100 column (0.7 X 30 cm) using buffer 
A. Fractions containing PPase activity were pooled 
and concentrated as above. 
Protein was determined as in [ 111. Molecular 
weight of the phosphatase was estimated by sodium 
dodecylsulfate (SDS)-polyac~lamide gel electropho- 
resis [ 121. 
3, Results and discussion 
3.1, Properties of the low M, phosphatase 
A relatively simple scheme for the puri~cation to 
apparent homogeneity of myelin associated PPase is 
presented in table 1. After ethanol precipitation, the 
activity of most phosphorylase phosphatases has been 
reported to increase [10,13-163. On the contrary, 
the activity of the PPase solubilized from myeiin 
decreased by 45% on ethanol precipitation when 
assayed with phosphorylated basic protein or his- 
tones. A similar loss in activity has been observed 
during the purification of rat liver PPase [17]. As 
reported for other PPases, the highI$ form of the 
myelin PPase dissociated to a low M, form by ethanol 
treatment at room temperature (fig.1). This form of 
the enzyme could then be purified to apparent 
homogeneity by the 3 additional steps given in 
table 1. When the enzyme purified through step 5, 
table 1 was subjected to SDS-polyacryiam~de gel 
electrophoresis, it revealed a single protein band of 
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Fig.1, Chromatography of human myelin phosphoprotein 
phosphatase onBiogel A-l .5 m column before and after 
ethanol precipitation. Phospho~otein p~ospha~se carried 
through purification Steps 1. (+---a) and 2 (O---O) of 
table 1 was separately chromatographed over a Biogel A-l .5 m 
column under conditions in the text. Phosphorylated human 
myelin basic protein was used to assay the phosphatase 
activity. The column was calibrated with proteins of known 
Mr: (a) beef liver catalase (250 000); (b) ovalbumin (43 000). 
The void volume (V,) was determined by chromatographing 
blue dextran 2000. 
Mr 46 000 (fig.2). The phosphatase activity emerged 
as a symmetrical peak from Sephadex G-100 column 
with an estimated Mr 50 000. Therefore these obser- 
vations indicate that the low &fr phosphatase may be 
constituted by a single polypeptide chain. 
Table 1 
Purification of human myelin phosphoprote~ phosphatase 
Step Total units Units/mg protein Yield(%) 
1.100000xg 
supernatant 13.2a 3.8 100 
2. Extract of 
ethanol precipitate 7.1 5.9 54 
3. Biogel A-l Sm 6.7 10.7 51 
4. DE 52 cellulose 2.0 29.9 15 
5. Sephadex G-100 0.7 14.6 5 
a The number represents the total activity in 1 ml 100 000 X g supernatant 
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Fig.2. Estimation of the molecular weight of purified phos- 
phatase by SDS-polyacrylamide gel electrophoresis. The 
standard curve was constructed using following proteins: 
(a) bovine serum albumin (68 000); (b) heavy chain of 
human r-globulin (SO 000); (c) ovalbumin (43 000); (d) 
light chain of human r-globulin (22 000); (e) lysozyme 
(14 300). The PPase purified through step 5, table 1 when 
electrophoresed under identical conditions migrated to a 
position which corresponds to MI 46 000. 
The optimal activity with basic protein was 
expressed in the presence of 125 nM Mn2+ and 5 mM 
dithiothreital. The enzyme was inactive when tested 
with p-nitrophenyl phosphate as the substrate. 
The activity of the highly purified PPase is com- 
paratively unstable. It has not yet been possible to 
stabilize the activity of the low M, PPase. In com- 
parison with the starting material the highly purified 
enzyme (step 5, table 1) showed only a 4-fold 
increase in its specific activity. However, due to the 
inherent instability of the purified PPase, both the 
specific activity as well as the yield of the final prepa- 
ration are substantially underestimated. 
3.2. Substrate specificity and activation of the high 
Mr phosphatase by cations 
A number of phosphoprotein phosphatases pos- 
sessing broad substrate specificity have been 
described. Some of these enzymes are activated by 
divalent cations. When the high MI phosphatase was 
incubated with Mn’+ prior to the addition of the sub- 
strate, there was a marked activation (-4-fold) in the 
rate at which it abstracted phosphate from myelin 
basic protein (flg.3). For maximum activation a 30 
jjYGEE%S 
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Fig.3. Time course of activation of the large molecular weight 
phosphoprotein phosphatase by MI?+. The myelin phos- 
phatase (step 1 of table 1) was preincubated with 125 PM 
MnZ+ for the time intervals shown. The activity was then 
determined as described in the text with the following 
phosphoproteins: human myelin basic protein (0); protamine 
(0); mixed histones (0); arginine-rich istones (m); and lysine- 
rich histones (A). 
min preincubation period in the presence of 125 /.&I 
Mn2+ was found to be optimal. This activation occur- 
red only when basic protein served as the substrate 
since the rate of dephosphorylation was not enhanced 
when the enzyme was assayed with protamine, mixed 
histones, lysine-rich histones, or arginine-rich histones 
(fig.3). 
We have explored the possibility whether activa- 
tion of the high M, PPase by Mn2+ involves its con- 
version to the low Mr species. The data obtained 
(not included) suggest hat the molecular weight of 
the PPase does not change during its activation by 
divalent cation. Thus far only the high Mr PPase 
could be activated by divalent cations. Attempts to 
activate the low Mr PPase have not been successful. 
The mechanism by which the divalent cation stim- 
ulates high Mr phosphatase is not yet known. It is 
possible that the binding of cation may cause confor- 
mational change in the high M, PPase thus facilitating 
recognition of the environment existing at the phos- 
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phate carrying site of the substrate. Such conforma- 
tional change may not be necessary for binding of the 
low A4r PPase to its substrate. 
Besides Mn2+, amuch higher concentration of 
Mg2+ (10 mM) activated the high Mr PPase -4-5-fold. 
This activation was also observed only when the activ- 
ity was assayed with phosphorylated basic protein. 
Both Zn2+ and orthovanadate inhibited the PPase 
activity. These experiments were conducted with 
basic protein as the substrate. In the presence of 0.1, 
0.5 and 1 .O mM Zn2+ the enzymatic activity was 
inhibited by 43,72 and 80%, respectively. In the 
presence of 2,10 and 50 PM orthovanadate, the loss 
in enzymatic activity corresponded to 63,85 and 
92%, respectively. 
Like activation by Mn2+ and Mg ‘+, the inhibition 
of PPase activity by Zn2+ was most noticeable with 
basic protein as the substrate. The PPase activity was 
not affected by Zn2+ when assayed with mixed 
histones, lysine-rich istones and arginine-rich his- 
tones. 
These results indicate that the myelin-associated 
PPase preferentially abstracts phosphate from myelin 
basic protein, perhaps its natural substrate. Further, 
the activity of this PPase may be regulated by diva- 
lent cations. 
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